Taniguchi Yuji, Nakamura Hiroshige, Miwa Ken, Haruki Tomohiro, Araki Kunio, Takagi Yuzo, Wakahara Makoto, Yurugi Yohei, Kubouchi Yasuaki, Ohno Takashi, Kidokoro Yoshiteru, Fujiwara Wakako
Division of General Thoracic Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
Yonago Acta Med. 2017 Sep 15;60(3):162-166. eCollection 2017 Sep.
At the end of 2016, robot-assisted thoracoscopic surgery (RATS) was still not covered by Japanese national health insurance. Therefore, few institutions in Japan perform RATS and even fewer have reported procedures as they occurred earlier. So, we decided to focus on the initial results of RATS for primary lung cancer.
We retrospectively reviewed 44 patients who underwent RATS for primary lung cancer from January 2011 to August 2016. After mastering the initial procedure, we introduced a completely portal robotic pulmonary resection procedure using a carbon dioxide insufflation system. Cases were divided into 2 groups: the early period (20 cases) and the later period (24 cases).
There was no case of conversion to video-assisted thoracoscopic surgery or thoracotomy. In the 44 cases of primary lung cancer, median operating time was 239.5 min, console time was 179 min, blood loss was 10 mL, drainage period was 2 days, morbidity of Grade 2 or more (Clavien-Dindo classification) was 18.2%, morbidity of Grade 3 or more was only 4.6%, and there was no 30-day mortality. Median operating and console times were significantly shorter in the later period (215 min and 159.5 min, respectively) than in the initial period (300.5 min and 228 min, respectively). Median blood loss was significantly lower in the later period (5 mL) than in the initial period (50 mL). Five-year overall and disease-free survival rates were 100% and 88.9%, respectively.
RATS for primary lung cancer is feasible and safe, has a faster learning curve, and provides satisfactory. Studies with longer follow-ups and larger numbers of cases are necessary.
2016年底,机器人辅助胸腔镜手术(RATS)仍未被纳入日本国民健康保险范围。因此,日本很少有机构开展RATS,且鲜有机构报告早期开展的手术情况。所以,我们决定关注RATS治疗原发性肺癌的初期结果。
我们回顾性分析了2011年1月至2016年8月期间接受RATS治疗原发性肺癌的44例患者。在掌握了初始手术方法后,我们引入了使用二氧化碳充气系统的完全经胸壁机器人肺切除术。病例分为2组:早期(20例)和后期(24例)。
无一例转为电视辅助胸腔镜手术或开胸手术。在44例原发性肺癌病例中,中位手术时间为239.5分钟,控制台操作时间为179分钟,失血量为10毫升,引流时间为2天,2级或更高等级(Clavien-Dindo分类)的并发症发生率为18.2%,3级或更高等级的并发症发生率仅为4.6%,且无30天死亡率。后期的中位手术时间和控制台操作时间(分别为215分钟和159.5分钟)明显短于初期(分别为300.5分钟和228分钟)。后期的中位失血量(5毫升)明显低于初期(50毫升)。五年总生存率和无病生存率分别为100%和88.9%。
RATS治疗原发性肺癌是可行且安全的,学习曲线更快,效果令人满意。有必要进行更长时间随访和更大样本量的研究。